| Title |
Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care
|
|---|---|
| Published in |
Therapeutics and Clinical Risk Management, February 2020
|
| DOI | 10.2147/tcrm.s219979 |
| Pubmed ID | |
| Authors |
Marco Luigetti, Angela Romano, Andrea Di Paolantonio, Giulia Bisogni, Mario Sabatelli |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 137 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 19 | 14% |
| Student > Bachelor | 14 | 10% |
| Student > Master | 10 | 7% |
| Researcher | 9 | 7% |
| Unspecified | 8 | 6% |
| Other | 20 | 15% |
| Unknown | 57 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 17% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 9% |
| Biochemistry, Genetics and Molecular Biology | 10 | 7% |
| Unspecified | 8 | 6% |
| Social Sciences | 6 | 4% |
| Other | 14 | 10% |
| Unknown | 63 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 75. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2024.
All research outputs
#570,811
of 25,385,509 outputs
Outputs from Therapeutics and Clinical Risk Management
#22
of 1,323 outputs
Outputs of similar age
#14,469
of 470,128 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#1
of 14 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 470,128 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.